The National Coalition for Cancer Survivorship (NCCS) is proud to announce the participants of the 2022 – 2023 Elevating Survivorship program. After a competitive application process, NCCS selected 11 individuals from across the United States to serve as Elevate Ambassadors.
The Elevate Ambassadors will receive support, mentorship, networking opportunities, and training from NCCS to help them successfully create and implement a project that will improve cancer survivorship care in their community. Some advocates will focus specifically on addressing health inequities highlighted in NCCS’s 2021 State of Cancer Survivorship Survey.
“We believe collaboration at the local level is key to fulfilling NCCS’s mission of ensuring that all cancer survivors receive quality care. It is an honor to welcome these incredible Elevate Ambassadors to our family as we work together to advance the cancer survivorship cause,” said NCCS CEO Shelley Fuld Nasso.
“The Elevating Survivorship program is an opportunity for advocates to lead the charge in improving survivorship care in their community,” said NCCS Vice President of External Relations Elena Jeannotte. “Each ambassador brings unique perspectives and experiences. We look forward to kicking it off in May.”
# # #
Grant funding for the 2022 – 2023 Elevating Survivorship program provided by Bristol-Myers Squibb, Janssen Oncology, and Pharmacyclics.